Pharmaron Biologics
康龙生物
Pharmaron Biologics
Biotech/Healthcare
Kanglong Biology was established in October 2020 in Ningbo’s Qianwan New Area. It is a key business segment of Pharmaron in CRO and CDMO services for biologics and cell and gene therapy products.
Latest round: Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.